Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1982 Dec;79(24):7857–7861. doi: 10.1073/pnas.79.24.7857

Human T cell hybridomas secreting immune interferon.

J Le, J Vilcek, C Saxinger, W Prensky
PMCID: PMC347448  PMID: 6818554

Abstract

Human T-cell hybridomas were established by hybridization of concanavalin A-stimulated human peripheral blood lymphocytes with a 6-thioguanine-resistant mutant cell line, designated SH9, derived by irradiation from a cloned human cutaneous T lymphoma line, Hut102-B2. High levels of interferon (IFN) were demonstrated in the supernatants of hybridoma L265 and its subclones. Whereas no IFN was detected in SH9 cell cultures, up to 1,330 units of IFN per ml were produced spontaneously by the hybrids. On induction with 12-omicron-tetradecanoylphorbol 13-acetate, IFN synthesis in hybridoma cultures was enhanced 8- to 16-fold. Neutralization with specific antisera and determination of antiviral activities in human and bovine cells showed that the IFN secreted by the hybridomas was immune IFN (IFN-gamma). Analysis of DNA content, karyotype, and cell surface phenotype, including T cell specific antigens and receptors, confirmed the T cell hybrid nature of L265 clones. No correlation was found in the hybridomas between IFN production and the expression of HTLV, a retrovirus released by Hut102-B2 and SH9 cells.

Full text

PDF
7857

Images in this article

7859Image
on p.7859

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Altman A., Sferruzza A., Weiner R. G., Katz D. H. Constitutive and mitogen-induced production of T cell growth factor by stable T cell hybridoma lines. J Immunol. 1982 Mar;128(3):1365–1371. [PubMed] [Google Scholar]
  2. Apte R. N., Eshhar Z., Löwy I., Zinger H., Mozes E. Characteristics of a poly(LTyr,LGlu)-poly(DLAla)--poly(LLys)-specific helper factor derived from a T cell hybridoma. Eur J Immunol. 1981 Nov;11(11):931–936. doi: 10.1002/eji.1830111115. [DOI] [PubMed] [Google Scholar]
  3. Clark-Lewis I., Schrader J. W. Biochemical characterization of regulatory factors derived from T cell hybridomas and spleen cells. I. Separation of T cell growth factor and T cell replacing factor from granulocyte-macrophage colony-stimulating factor. J Immunol. 1982 Jan;128(1):168–174. [PubMed] [Google Scholar]
  4. Darzynkiewicz Z., Traganos F., Sharpless T., Melamed M. R. Lymphocyte stimulation: a rapid multiparameter analysis. Proc Natl Acad Sci U S A. 1976 Aug;73(8):2881–2884. doi: 10.1073/pnas.73.8.2881. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Farrar J. J., Benjamin W. R., Hilfiker M. L., Howard M., Farrar W. L., Fuller-Farrar J. The biochemistry, biology, and role of interleukin 2 in the induction of cytotoxic T cell and antibody-forming B cell responses. Immunol Rev. 1982;63:129–166. doi: 10.1111/j.1600-065x.1982.tb00414.x. [DOI] [PubMed] [Google Scholar]
  6. Gazdar A. F., Carney D. N., Bunn P. A., Russell E. K., Jaffe E. S., Schechter G. P., Guccion J. G. Mitogen requirements for the in vitro propagation of cutaneous T-cell lymphomas. Blood. 1980 Mar;55(3):409–417. [PubMed] [Google Scholar]
  7. Grillot-Courvalin C., Brouet J. C., Berger R., Bernheim A. Establishment of a human T-cell hybrid line with suppressive activity. Nature. 1981 Aug 27;292(5826):844–845. doi: 10.1038/292844a0. [DOI] [PubMed] [Google Scholar]
  8. Havell E. A., Vilcek J. Production of high-titered interferon in cultures of human diploid cells. Antimicrob Agents Chemother. 1972 Dec;2(6):476–484. doi: 10.1128/aac.2.6.476. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hayes T. G. Differences between human alpha (leukocyte) and beta (fibroblast) interferons. Arch Virol. 1981;67(4):267–281. doi: 10.1007/BF01314831. [DOI] [PubMed] [Google Scholar]
  10. Haynes B. F., Metzgar R. S., Minna J. D., Bunn P. A. Phenotypic characterization of cutaneous T-cell lymphoma. Use of monoclonal antibodies to compare with other malignant T cells. N Engl J Med. 1981 May 28;304(22):1319–1323. doi: 10.1056/NEJM198105283042202. [DOI] [PubMed] [Google Scholar]
  11. Irigoyen O., Rizzolo P. V., Thomas Y., Rogozinski L., Chess L. Generation of functional human T cell hybrids. J Exp Med. 1981 Dec 1;154(6):1827–1837. doi: 10.1084/jem.154.6.1827. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Jones C. M., Braatz J. A., Herberman R. B. Production of both macrophage activating and inhibiting activities by a murine T-lymphocyte hybridoma. Nature. 1981 Jun 11;291(5815):502–503. doi: 10.1038/291502a0. [DOI] [PubMed] [Google Scholar]
  13. Kalyanaraman V. S., Sarngadharan M. G., Nakao Y., Ito Y., Aoki T., Gallo R. C. Natural antibodies to the structural core protein (p24) of the human T-cell leukemia (lymphoma) retrovirus found in sera of leukemia patients in Japan. Proc Natl Acad Sci U S A. 1982 Mar;79(5):1653–1657. doi: 10.1073/pnas.79.5.1653. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kaufmann Y., Berke G., Eshhar Z. Cytotoxic T lymphocyte hybridomas that mediate specific tumor-cell lysis in vitro. Proc Natl Acad Sci U S A. 1981 Apr;78(4):2502–2506. doi: 10.1073/pnas.78.4.2502. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kobayashi Y., Asada M., Higuchi M., Osawa T. Human T cell hybridomas producing lymphokines. I. Establishment and characterization of human T cell hybridomas producing lymphotoxin and migration inhibitory factor. J Immunol. 1982 Jun;128(6):2714–2718. [PubMed] [Google Scholar]
  16. Krupen K., Araneo B. A., Brink L., Kapp J. A., Stein S., Wieder K. J., Webb D. R. Purification and characterization of a monoclonal T-cell suppressor factor specific for poly(LGlu60LAla30LTyr10). Proc Natl Acad Sci U S A. 1982 Feb;79(4):1254–1258. doi: 10.1073/pnas.79.4.1254. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Lonai P., Puri J., Bitton S., Ben-Neriah Y., Givol D., Hämmerling G. J. H-2-restricted helper factor secreted by clone hybridoma cells. J Exp Med. 1981 Sep 1;154(3):942–951. doi: 10.1084/jem.154.3.942. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Minami M., Okuda K., Furusawa S., Benacerraf B., Dorf M. E. Analysis of T cell hybridomas. I. Characterization of H-2 and Igh-restricted monoclonal suppressor factors. J Exp Med. 1981 Nov 1;154(5):1390–1402. doi: 10.1084/jem.154.5.1390. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Misfeldt M. L., Hanna E. E. Complementation of the plaque-forming cell responses of T-cell-deficient nude mice by a T-cell hybridoma. Proc Natl Acad Sci U S A. 1981 Mar;78(3):1813–1817. doi: 10.1073/pnas.78.3.1813. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Nathan I., Groopman J. E., Quan S. G., Bersch N., Golde D. W. Immune (gamma) interferon produced by a human T-lymphoblast cell line. Nature. 1981 Aug 27;292(5826):842–844. doi: 10.1038/292842a0. [DOI] [PubMed] [Google Scholar]
  21. Okada M., Yoshimura N., Kaieda T., Yamamura Y., Kishimoto T. Establishment and characterization of human T hybrid cells secreting immunoregulatory molecules. Proc Natl Acad Sci U S A. 1981 Dec;78(12):7717–7721. doi: 10.1073/pnas.78.12.7717. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Poiesz B. J., Ruscetti F. W., Gazdar A. F., Bunn P. A., Minna J. D., Gallo R. C. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A. 1980 Dec;77(12):7415–7419. doi: 10.1073/pnas.77.12.7415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Puré E., Isakson P. C., Takatsu K., Hamaoka T., Swain S. L., Dutton R. W., Dennert G., Uhr J. W., Vitetta E. S. Induction of B cell differentiation by T cell factors. I. Stimulation of IgM secretion by products of a T cell hybridoma and a T cell line. J Immunol. 1981 Nov;127(5):1953–1958. [PubMed] [Google Scholar]
  24. Saxinger C. Evaluation of the parameters of the ELISA procedure for feline type C retroviral antigens: assay of FeLV antigens in chronically infected or nonproducer transformed cells. Intervirology. 1981;15(1):1–9. doi: 10.1159/000149208. [DOI] [PubMed] [Google Scholar]
  25. Schwaber J. Human lymphocyte-mouse myeloma somatic cell hybrids: selective hybrid formation. Somatic Cell Genet. 1977 May;3(3):295–302. doi: 10.1007/BF01538747. [DOI] [PubMed] [Google Scholar]
  26. Traganos F., Darzynkiewicz Z., Sharpless T., Melamed M. R. Simultaneous staining of ribonucleic and deoxyribonucleic acids in unfixed cells using acridine orange in a flow cytofluorometric system. J Histochem Cytochem. 1977 Jan;25(1):46–56. doi: 10.1177/25.1.64567. [DOI] [PubMed] [Google Scholar]
  27. VedBrat S. S., Hammerling U., Hardy W. D., Jr, Borenfreund E., Prensky W. Monoclonal antibodies: detection of transformation-related antigens. Cold Spring Harb Symp Quant Biol. 1980;44(Pt 1):715–720. doi: 10.1101/sqb.1980.044.01.076. [DOI] [PubMed] [Google Scholar]
  28. Whitaker R. B., Nepom J. T., Sy M. S., Takaoki M., Gramm C. F., Fox I., Germain R. N., Nelles M. J., Greene M. I., Benacerraf B. Suppressor factor from a T cell hybrid inhibits delayed-type hypersensitivity responses to azobenzenearsonate. Proc Natl Acad Sci U S A. 1981 Oct;78(10):6441–6445. doi: 10.1073/pnas.78.10.6441. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Yip Y. K., Barrowclough B. S., Urban C., Vilcek J. Purification of two subspecies of human gamma (immune) interferon. Proc Natl Acad Sci U S A. 1982 Mar;79(6):1820–1824. doi: 10.1073/pnas.79.6.1820. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Yip Y. K., Pang R. H., Oppenheim J. D., Nachbar M. S., Henriksen D., Zerebeckyj-Eckhardt I., Vilcek J. Stimulation of human gamma interferon production by diterpene esters. Infect Immun. 1981 Oct;34(1):131–139. doi: 10.1128/iai.34.1.131-139.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES